{"disease":{"id":"polymyositis","name":"polymyositis"},"drugs":{"marketed":[{"drug_id":"prednisone","indication_name":"Systemic dermatomyositis (polymyositis)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Deltasone","generic_name":"prednisone","company_name":"Generic (originally Schering)","drug_phase":"marketed","molecular_target":"Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor","drug_class":"Corticosteroid [EPC]","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03840928","title":"PatientSpot Formerly Known as ArthritisPower","phase":"","overall_status":"UNKNOWN","enrollment_count":40000,"lead_sponsor_name":"Global Healthy Living Foundation","has_results":false},{"nct_id":"NCT04402086","title":"Rheumatology Patient Registry and Biorepository","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Yale University","has_results":false},{"nct_id":"NCT00001265","title":"Study and Treatment of Inflammatory Muscle Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":1325,"lead_sponsor_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","has_results":false},{"nct_id":"NCT00017914","title":"Adult and Juvenile Myositis","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT00341679","title":"Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":719,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT01276470","title":"Environmental Risk Factors for the Anti-synthetase Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":580,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT06339957","title":"Rheumatology Diet Study","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Central Florida","has_results":false},{"nct_id":"NCT06383819","title":"Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":392,"lead_sponsor_name":"NPO Petrovax","has_results":false},{"nct_id":"NCT05523167","title":"A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":265,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT06455449","title":"A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":240,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06698796","title":"A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":211,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT06888973","title":"Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":200,"lead_sponsor_name":"National Institute of Blood and Marrow Transplant (NIBMT), Pakistan","has_results":false},{"nct_id":"NCT02159651","title":"A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia","phase":"","overall_status":"COMPLETED","enrollment_count":179,"lead_sponsor_name":"Astellas Pharma Inc","has_results":false},{"nct_id":"NCT02971683","title":"Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT01432613","title":"Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies","phase":"NA","overall_status":"COMPLETED","enrollment_count":139,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03941184","title":"Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity","phase":"","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05637931","title":"Plexin D1 as a Potential Biomarker inPM/DM","phase":"","overall_status":"UNKNOWN","enrollment_count":66,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03981744","title":"A Study of Ustekinumab in Participants With Active Polymyositis and Dermatomyositis Who Have Not Adequately Responded to One or More Standard-of-care Treatments","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":51,"lead_sponsor_name":"Janssen Pharmaceutical K.K.","has_results":true},{"nct_id":"NCT05650567","title":"Study of M5049 in DM and PM Participants (NEPTUNIA)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"EMD Serono Research & Development Institute, Inc.","has_results":false},{"nct_id":"NCT01734369","title":"Environmental Risk Factors for Myositis in Military Personnel","phase":"","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"National Institute of Environmental Health Sciences (NIEHS)","has_results":false},{"nct_id":"NCT02043548","title":"Tocilizumab in the Treatment of Refractory Polymyositis and Dermatomyositis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Chester Oddis","has_results":true},{"nct_id":"NCT02780674","title":"A Phase 1 Study of MEDI7734 in Type I Interferon-Mediated Autoimmune Diseases","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT04486261","title":"High-intensity Strength Training in Myositis","phase":"NA","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT03817424","title":"A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Amgen","has_results":false},{"nct_id":"NCT03324152","title":"Effects of High-intensity Interval Training (HIIT) in Recent Onset Polymyositis and Dermatomyositis","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Karolinska University Hospital","has_results":false},{"nct_id":"NCT04033926","title":"A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Kezar Life Sciences, Inc.","has_results":true},{"nct_id":"NCT06347718","title":"CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"Miltenyi Biomedicine GmbH","has_results":false},{"nct_id":"NCT03414086","title":"Predictor of Clinical Response to Acthar in Myositis","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"University of Pittsburgh","has_results":false},{"nct_id":"NCT04628936","title":"Open-label Extension to the Phase 2 Crossover Study (PRESIDIO) Evaluating KZR-616 in Patients With PM and DM.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Kezar Life Sciences, Inc.","has_results":true},{"nct_id":"NCT01148810","title":"Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":18,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT00033891","title":"Infliximab (Remicade ) to Treat Dermatomyositis and Polymyositis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","has_results":false},{"nct_id":"NCT01801917","title":"Efficacy and Tolerability of BAF312 in Patients With Polymyositis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04723303","title":"Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"University of Florida","has_results":false},{"nct_id":"NCT04976140","title":"Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"Paean Biotechnology Inc.","has_results":false},{"nct_id":"NCT05027152","title":"Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties","phase":"NA","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Federal University of Espirito Santo","has_results":false}],"total":35},"guidelines":[],"source":"Drug Landscape verified database"}